Page 205 - Read Online
P. 205

Page 24                Asao et al. Extracell Vesicles Circ Nucleic Acids 2023;4:461-85  https://dx.doi.org/10.20517/evcna.2023.37

                    Mater 2023;22:656-65.  DOI
               139.      Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling
                    compared to intracellular and cell-free blood. J Extracell Vesicles 2014;3:23743.  DOI  PubMed  PMC
               140.      Zhou E, Li Y, Wu F, et al. Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy.
                    EBioMedicine 2021;67:103365.  DOI  PubMed  PMC
               141.      Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature
                    2015;523:177-82.  DOI  PubMed  PMC
               142.      McKiernan J, Donovan MJ, O'Neill V, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at
                    initial biopsy. JAMA Oncol 2016;2:882-9.  DOI
               143.      Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva.
                    Blood 2011;117:3172-80.  DOI  PubMed
               144.      Lässer C, Alikhani VS, Ekström K, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J
                    Transl Med 2011;9:9.  DOI  PubMed  PMC
               145.      Herreros-Villanueva M, Bujanda L. Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. Ann Transl Med
                    2016;4:64.  DOI  PubMed  PMC
               146.      Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J
                    Extracell Vesicles 2015;4:27066.  DOI  PubMed  PMC
               147.      Øverbye A, Skotland T, Koehler CJ, et al. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget
                    2015;6:30357-76.  DOI  PubMed  PMC
               148.      Zhang C, Wang XY, Zhang P, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by
                    reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis 2022;13:57.  DOI  PubMed  PMC
               149.      Sun H, Wang C, Hu B, et al. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis
                    by activating STAT3. Signal Transduct Target Ther 2021;6:187.  DOI  PubMed  PMC
               150.      Plebanek MP, Angeloni NL, Vinokour E, et al. Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes
                    at the metastatic niche. Nat Commun 2017;8:1319.  DOI  PubMed  PMC
               151.      Balaj L, Lessard R, Dai L, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat
                    Commun 2011;2:180.  DOI  PubMed  PMC
               152.      Kahlert C, Melo SA, Protopopov A, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated
                    KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 2014;289:3869-75.  DOI  PubMed
                    PMC
               153.      Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res
                    2014;24:766-9.  DOI  PubMed  PMC
               154.      Lee TH, Chennakrishnaiah S, Audemard E, Montermini L, Meehan B, Rak J. Oncogenic ras-driven cancer cell vesiculation leads to
                    emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun 2014;451:295-301.  DOI
                    PubMed
               155.      Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology.
                    Nat Rev Genet 2019;20:71-88.  DOI  PubMed
               156.      Wan Y, Liu B, Lei H, et al. Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation
                    detection in early-stage non-small-cell lung cancer. Ann Oncol 2018;29:2379-83.  DOI  PubMed  PMC
               157.      Castillo J, Bernard V, San Lucas FA, et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid
                    biopsies from pancreatic cancer patients. Ann Oncol 2018;29:223-9.  DOI  PubMed  PMC
               158.      Lázaro-Ibáñez E, Sanz-Garcia A, Visakorpi T, et al. Different gDNA content in the subpopulations of prostate cancer extracellular
                    vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate 2014;74:1379-90.  DOI  PubMed  PMC
               159.      Krug AK, Enderle D, Karlovich C, et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor
                    DNA in NSCLC patient plasma. Ann Oncol 2018;29:700-6.  DOI  PubMed  PMC
               160.      Bernard V, Kim DU, San Lucas FA, et al. Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer.
                    Gastroenterology 2019;156:108-18.e4.  DOI  PubMed  PMC
               161.      Castellanos-Rizaldos E, Grimm DG, Tadigotla V, et al. Exosome-based detection of EGFR T790M in plasma from non-small cell
                    lung cancer patients. Clin Cancer Res 2018;24:2944-50.  DOI  PubMed
               162.      Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat
                    Rev Cancer 2017;17:223-38.  DOI
               163.      Cheng L, Hill AF. Therapeutically harnessing extracellular vesicles. Nat Rev Drug Discov 2022;21:379-99.  DOI  PubMed
               164.      Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-
                    derived exosomes. Nat Med 1998;4:594-600.  DOI  PubMed
               165.      Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of
                    targeted exosomes. Nat Biotechnol 2011;29:341-5.  DOI
               166.      Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
                    Nature 2017;546:498-503.  DOI  PubMed  PMC
               167.      Mendt M, Kamerkar S, Sugimoto H, et al. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight
   200   201   202   203   204   205   206   207   208   209   210